ALLERTIN CAPSULE

国家: 加拿大

语言: 英文

来源: Health Canada

有效成分:

LORATADINE

可用日期:

APOTEX INC

ATC代码:

R06AX13

INN（国际名称）:

LORATADINE

剂量:

10MG

药物剂型:

CAPSULE

组成:

LORATADINE 10MG

给药途径:

ORAL

每包单位数:

12/24

处方类型:

OTC

治疗领域:

SECOND GENERATION ANTIHISTAMINES

產品總結:

Active ingredient group (AIG) number: 0120416001; AHFS:

授权状态:

APPROVED

授权日期:

2012-08-02

产品特点

Page 2 of 20
PRODUCT MONOGRAPH
ALLERTIN
LORATADINE CAPSULES, 10 MG
HISTAMINE H
1 RECEPTOR ANTAGONIST
APOTEX INC.
DATE OF REVISION:
150 SIGNET DRIVE
SEPTEMBER 25, 2019
TORONTO, ONTARIO
CANADA M9L 1T9
CONTROL #: 231181
Page 3 of 20
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.......................................................................
4
SUMMARY PRODUCT INFORMATION
.............................................................................................
4
INDICATIONS AND CLINICAL USE
...................................................................................................
4
CONTRAINDICATIONS
........................................................................................................................
4
WARNINGS AND PRECAUTIONS
.......................................................................................................
4
ADVERSE REACTIONS
.........................................................................................................................
5
DRUG INTERACTIONS
.........................................................................................................................
6
DOSAGE AND ADMINISTRATION
.....................................................................................................
7
OVERDOSAGE
.......................................................................................................................................
7
ACTION AND CLINICAL
PHARMACOLOGY....................................................................................
8
STORAGE AND STABILITY
.................................................................................................................
9
SPECIAL HANDLING INSTRUCTIONS
..............................................................................................
9
DOSAGE FORMS, COMPOSITION AND PACKAGING
.................................................................... 9
PART II: SCIENTIFIC INFORMATION
.....................................................................